Charles River Laboratories (CRL) Tops Q4 EPS by 4c

February 13, 2013 4:31 PM EST Send to a Friend
Charles River Laboratories (NYSE: CRL) reported Q4 EPS of $0.64, $0.04 better than the analyst estimate of $0.60. Revenue for the quarter came in at $280.1 million versus the consensus estimate of $280.81 million.

Charles River Laboratories reaffirmed FY2013 guidance.

For earnings history and earnings-related data on Charles River Laboratories (CRL) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment